According to Bliss GVS Pharma's latest financial reports and stock price the company's current Operating Margin is 19.10%. At the end of 2022 the company had an Operating Margin of 7.34%.
Year | Operating Margin | Change |
---|---|---|
2022 | 7.34% | -59.91% |
2021 | 18.31% | -3.18% |
2020 | 18.91% | -7.88% |
2019 | 20.53% | 16.72% |
2018 | 17.59% | -21.49% |
2017 | 22.40% | -17.32% |
2016 | 27.10% | 14.9% |
2015 | 23.58% | 15.94% |
2014 | 20.34% | -26.31% |
2013 | 27.60% | -7.31% |
2012 | 29.78% | 23.01% |
2011 | 24.21% | -10.64% |
2010 | 27.09% | -10.51% |
2009 | 30.28% | -12.01% |
2008 | 34.41% | 265.8% |
2007 | 9.41% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.